Beaphar Worming Syrup, 9.4% w/v, Oral Solution
Piperazine Citrate
Last verified
Veterinary medicinal product: oral solution. Distribution category: AVM-GSL (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Piperazine Citrate.1
In short: questions and answers
- Does Beaphar Worming Syrup, 9.4% w/v, Oral Solution need a prescription?
- Over the counter. As stated in the registration decision.1
- Which animals is Beaphar Worming Syrup, 9.4% w/v, Oral Solution for?
- Cats, Dogs.1
- What is the active substance in Beaphar Worming Syrup, 9.4% w/v, Oral Solution?
- Piperazine Citrate. ATCvet code: QP52AH01.13
- What is the withdrawal period of Beaphar Worming Syrup, 9.4% w/v, Oral Solution according to the leaflet?
- No withdrawal period is set for this drug: it is not intended for food-producing animals.3
- Dispensing
- Over the counter1
AVM-GSL: Authorised Veterinary Medicine - General Sale List. No prescription is needed and it may be sold by any retailer.12
Supplied without a prescription. As stated in the registration decision.
- Active substance
- Piperazine Citrate
- ATCvet code
- QP52AH013
- Manufacturer
- Marketing authorisation holder: Beaphar UK Ltd
Withdrawal period
No withdrawal period is set for this drug: it is not intended for food-producing animals.3
Summary of product characteristics
Composition
| Active substance | % w/v |
|---|---|
| Piperazine Citrate | 9.4 |
Excipients
Methyl Parahydroxybenzoate 0.040% w/v
Ethyl Parahydroxybenzoate 0.010% w/v
Propyl Parahydroxybenzoate 0.005% w/v
Butyl Parahydroxybenzoate 0.015% w/v
For full list of excipients, see section 6.1
6.1 List of excipients
Methyl Parahydroxybenzoate
Ethyl Parahydroxybenzoate
Propyl Parahydroxybenzoate
Butyl Parahydroxybenzoate
Sorbitol Solution 70% w/w (Non-Crystallising)
Imitation Chocolate Flavour 1470
Caramel T6
Water Deionised
Pharmaceutical form
Oral solution.
Bright reddish brown, clear solution.
Pharmacological properties
ATCvet code: QP52AH01
5.1 Pharmacodynamic properties
Worms are killed in the gastro-intestinal tract and may be expelled in the faeces or digested in their passage through the tract.
5.2 Pharmacokinetic particulars
None given.
Target species
Dogs and cats.
Indications
For the treatment of roundworms (Ascarids) in puppies and kittens.
Dosage
For oral administration.
Administer directly into the corner of the mouth, or mixed with a little food. The rest of the meal should be offered afterwards to ensure all the syrup is taken.
Shake the bottle and prime dispenser before use by slowly depressing the plunger repeatedly, up to 5 times.
| Animal Weight/kg | Number of pumps |
|---|---|
| Up to 0.9 | 1 (1.1 ml) |
| 0.91 - 1.8 | 2 (2.2 ml) |
| 1.81 - 2.7 | 3 (3.3 ml) |
| 2.71 - 3.6 | 4 (4.4 ml) |
| 3.61 - 4.5 | 5 (5.5 ml) |
| 4.51 - 5.4 | 6 (6.6 ml) |
For every additional 0.9 kg bodyweight, an extra single pump volume should be administered.
Puppies and kittens should be treated for roundworms at 2 weeks of age. They should be re-treated at 4, 6, 8, 10 and 12 weeks of age, and thereafter at 2 to 3 monthly intervals.
Contraindications
Do not exceed stated dose.
Do not repeat treatment if vomiting occurs shortly after dosing.
Adverse reactions
During post-marketing surveillance, transient gastrointestinal signs (emesis and diarrhoea) have been observed very rarely.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Warnings
i. Special precautions for use in animals
Do not exceed the recommended dosage.
ii. Special precautions to be taken by the person administering the medicinal product to animals
Following accidental skin or eye contact, wash the affected area with plenty of water. If irritation persists, seek medical advice.
Following accidental ingestion, drink plenty of water and seek medical attention. Wash hands after use.
Use during pregnancy, lactation or lay
Consult a veterinary surgeon before treating pregnant animals.
Nursing female animals should be treated 2 weeks after giving birth and every two weeks at the same time as the puppies or kittens until weaning.
Interactions
None known.
Overdose
Symptoms: Vomiting and diarrhoea, depression, ataxia, muscle weakness, and fits.
Emergency Procedures: Consult a veterinary surgeon.
Treat symptomatically and supportively.
Keep animal warm and calm.
Symptoms reverse in 24 - 48 hours.
Special warnings
Consult a veterinary surgeon before treating pregnant animals, or those with a history of epilepsy or severe renal disfunction.
Withdrawal period
Not applicable
Incompatibilities
None known.
Immediate packaging
Size: 45 ml
Container: Round, amber Type III glass bottle.
Closure: White, tamper-evident polypropylene cap (screw fit) with low-density polyethylene liner.
Dosing device: Pump dispenser nominally delivering 1.1 ml per stroke
Use Orientation: Upright
Storage
Do not store above 25°C.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years.
Disposal of unused product
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Additional information
Vm 13907/5013
9 DATE OF FIRST AUTHORISATION
21 September 1994
10 DATE OF REVISION OF THE TEXT
November 2025
Gavin Hall Approved: 12 November 2025
Registration holder
Beaphar UK Ltd
Rook Tree Farm
Withersfield Road
Great Wratting
Suffolk
CB9 7HD
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32